Vranckx P - Search Results

1

A global risk approach to identify patients with left main or 3-vessel disease who could safely and efficaciously be treated with percutaneous coronary intervention: the SYNTAX Trial at 3 years.

Serruys PW, Farooq V, Vranckx P, Girasis C, Brugaletta S, Garcia-Garcia HM, Holmes DR Jr, Kappetein AP, Mack MJ, Feldman T, Morice MC, Ståhle E, James S, Colombo A, Pereda P, Huang J, Morel MA, Van Es GA, Dawkins KD, Mohr FW, Steyerberg EW. Serruys PW, et al. Among authors: vranckx p. JACC Cardiovasc Interv. 2012 Jun;5(6):606-17. doi: 10.1016/j.jcin.2012.03.016. JACC Cardiovasc Interv. 2012. PMID: 22721655 Free article. Clinical Trial.

2

Usefulness of percutaneous left ventricular assistance to support high-risk percutaneous coronary interventions.

Lemos PA, Cummins P, Lee CH, Degertekin M, Gardien M, Ottervanger JP, Vranckx P, de Feyter P, Serruys PW. Lemos PA, et al. Among authors: vranckx p. Am J Cardiol. 2003 Feb 15;91(4):479-81. doi: 10.1016/s0002-9149(02)03254-x. Am J Cardiol. 2003. PMID: 12586273 No abstract available.

3

Clinical introduction of the Tandemheart, a percutaneous left ventricular assist device, for circulatory support during high-risk percutaneous coronary intervention.

Vranckx P, Foley DP, de Feijter PJ, Vos J, Smits P, Serruys PW. Vranckx P, et al. Int J Cardiovasc Intervent. 2003;5(1):35-9. doi: 10.1080/14628840304611. Int J Cardiovasc Intervent. 2003. PMID: 12623563

4

Clinical development of bivalirudin (Angiox): rationale for thrombin-specific anticoagulation in percutaneous coronary intervention and acute coronary syndromes.

Serruys PW, Vranckx P, Allikmets K. Serruys PW, et al. Among authors: vranckx p. Int J Clin Pract. 2006 Mar;60(3):344-50. doi: 10.1111/j.1368-5031.2005.00823.x. Int J Clin Pract. 2006. PMID: 16494651 Review.

5

Clinical end points in coronary stent trials: a case for standardized definitions.

Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, Steg PG, Morel MA, Mauri L, Vranckx P, McFadden E, Lansky A, Hamon M, Krucoff MW, Serruys PW; Academic Research Consortium. Cutlip DE, et al. Among authors: vranckx p. Circulation. 2007 May 1;115(17):2344-51. doi: 10.1161/CIRCULATIONAHA.106.685313. Circulation. 2007. PMID: 17470709

6

Multivessel coronary revascularization in patients with and without diabetes mellitus: 3-year follow-up of the ARTS-II (Arterial Revascularization Therapies Study-Part II) trial.

Daemen J, Kuck KH, Macaya C, LeGrand V, Vrolix M, Carrie D, Sheiban I, Suttorp MJ, Vranckx P, Rademaker T, Goedhart D, Schuijer M, Wittebols K, Macours N, Stoll HP, Serruys PW; ARTS-II Investigators. Daemen J, et al. Among authors: vranckx p. J Am Coll Cardiol. 2008 Dec 9;52(24):1957-67. doi: 10.1016/j.jacc.2008.09.010. J Am Coll Cardiol. 2008. PMID: 19055986 Free article. Clinical Trial.

7

The TandemHeart, percutaneous transseptal left ventricular assist device: a safeguard in high-risk percutaneous coronary interventions. The six-year Rotterdam experience.

Vranckx P, Meliga E, De Jaegere PP, Van den Ent M, Regar ES, Serruys PW. Vranckx P, et al. EuroIntervention. 2008 Nov;4(3):331-7. doi: 10.4244/eijv4i3a60. EuroIntervention. 2008. PMID: 19110806 Clinical Trial.

8

Proof-of-concept trial to evaluate haemoglobin based oxygen therapeutics in elective percutaneous coronary revascularisation. Rationale, protocol design and haemodynamic results.

Meliga E, Vranckx P, Regar E, Kint PP, Duncker DJ, Serruys PW. Meliga E, et al. Among authors: vranckx p. EuroIntervention. 2008 May;4(1):99-107. doi: 10.4244/eijv4i1a17. EuroIntervention. 2008. PMID: 19112786 Clinical Trial.

9

Identifying stent thrombosis, a critical appraisal of the academic research consortium (ARC) consensus definitions: a lighthouse and as a toe in the water.

Vranckx P, Kint PP, Morel MA, Van Es GA, Serruys PW, Cutlip DE. Vranckx P, et al. EuroIntervention. 2008 Aug;4 Suppl C:C39-44. EuroIntervention. 2008. PMID: 19202690 No abstract available.

10

Assisted circulation using the TandemHeart during very high-risk PCI of the unprotected left main coronary artery in patients declined for CABG.

Vranckx P, Schultz CJ, Valgimigli M, Eindhoven JA, Kappetein AP, Regar ES, Van Domburg R, Serruys PW. Vranckx P, et al. Catheter Cardiovasc Interv. 2009 Aug 1;74(2):302-10. doi: 10.1002/ccd.22011. Catheter Cardiovasc Interv. 2009. PMID: 19360865

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

310 results

Search Page

Filters